Michael Gibson: New California law prohibits payers from making coverage decisions based solely on AI
Michael Gibson, CEO of Baim Institute for Clinical Research, shared a post on X:
“New California law prohibits payers from making coverage decisions based solely on artificial intelligence.
Any denial, delay or modification of care based on medical necessity must be reviewed and decided by a licensed MD or qualified healthcare professional with expertise in the specific clinical issue.”
More posts featuring Michael Gibson.
C. Michael Gibson, M.S., M.D., is the CEO of Baim Institute for Clinical Research at Harvard Medical School. He is a Professor of Medicine at Harvard Medical School and an Interventional Cardiologist at Beth Israel Deaconess Medical Center, an affiliate of Harvard.
Dr. Gibson is also the Chairman of the Board, Founder, and Editor-In-Chief of WikiDoc Foundation, and an Executive Board Member of EXCITE International.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023